Plasminogen inhibits TNFα-induced apoptosis in monocytes

Blood

Volumn 107, Issue 11, 2006, Pages 4383-4390

  Mitchell, Jennifer W ^a   Baik, Nagyung ^b   Castellino, Francis J ^b   Miles, Lindsey A ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLOHEXIMIDE; DNA FRAGMENT; PLASMIN; PLASMINOGEN; PROTEINASE ACTIVATED RECEPTOR 1; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; CASPASE;

APOPTOSIS; ARTICLE; CELL PROTECTION; DOSE RESPONSE; DRUG INHIBITION; HUMAN; HUMAN CELL; MONOCYTE; MUTANT; PRIORITY JOURNAL; PROTEIN DEGRADATION; AMINO ACID SUBSTITUTION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY;

AMINO ACID SUBSTITUTION; APOPTOSIS; CASPASES; CELLS, CULTURED; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MONOCYTES; PLASMIN; PLASMINOGEN; RECEPTOR, PAR-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744482011     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-07-2872     Document Type: Article

References (69)

1. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 1993;260:496-497.
2. Solbach W, Moll H, Rollinghoff M. Lymphocytes play the music but the macrophage calls the tune. Immunol Today. 1991;12:4-6.
3. Kuhn J, Godshall CJ, Scott MJ. Immediate and delayed leukocyte apoptosis in two models of peritonitis. Inflammation. 2001;25:389-397.
4. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood. 1998;91:2005-2009.
5. Plow EF, Ploplis VA, Carmeliet P, Collen D. Plasminogen and cell migration in vivo. Fibrinolysis Proteolysis. 1999;13:49-53.
6. Moons L, Shi C, Ploplis V, et al. Reduced transplant arteriosclerosis in plasminogen-deficient mice. J Clin Invest. 1998;102:1788-1797.
7. Busso N, Peclat V, So A, Sappino AP. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis. 1997;56:550-557.
8. Jenkins GR, Seiffert D, Parmer RJ, Miles LA. Regulation of plasminogen gene expression by interleukin-6. Blood. 1997;89:2394-2403.
9. Bannach FG, Gutierrez A, Fowler BJ, et al. Localization of regulatory elements mediating constitutive and cytokine-stimulated plasminogen gene expression. J Biol Chem. 2002;277:38579-38588.
10. Gutierrez-Fernandez A, Gingles NA, Zhang L, et al. Regulation of plasminogen gene expression. In: Waisman DM, ed. Plasminogen Regulation. New York: Academic/Plenum Publishers; 2003:67-80.
11. Bannach FG, Gutierrez-Fernandez A, Parmer RJ, Miles LA. Interleukin-6-induced plasminogen gene expression in murine hepatocytes is mediated by transcription factor CCAAT/enhancer binding protein beta (C/EBPbeta). J Thromb Haemost. 2004;2:2205-2212.
12. Tsirka SE, Bugge TH, Degen JL, Strickland S. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci U S A. 1997;94:9779-9781.
13. Chen-Liu LW, Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell. 1997;91:917-925.
14. Houard X, Monnot C, Dive V, Corvol P, Pagano M. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin. J Cell Biochem. 2003;88:1188-1201.
15. Meilhac O, Ho-Tin-Noe B, Houard X, et al. Pericellular plasmin induces smooth muscle cell anoikis. FASEB J. 2003;17:1301-1303.
16. Zhang X, Chaudhry A, Chintala SK. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Mol Vis. 2003;9:238-248.
17. Rossignol P, Ho-Tin-Noe B, Vranckx R, et al. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. J Biol Chem. 2004;279:10346-10356.
18. O'Mullane MJ, Baker MS. Loss of cell viability dramatically elevates cell surface plasminogen binding and activation. Exp Cell Res. 1998;242:153-164.
19. O'Mullane MJ, Baker MS. Elevated plasminogen receptor expression occurs as a degradative phase even in cellular apoptosis. Immunol Cell Biol. 1999;77:249-255.
20. Gong Y, Kim S-O, Felez J, et al. Conversion of glu-plasminogen to lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface. J Biol Chem. 2001;276:19078-19083.
21. Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen: isolation of two lysine-binding fragments and one "mini-"plasminogen (MW 38,000) by elastase-catalyzed-specific limited proteolysis. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC, eds. Progress in Chemical Fibrinolysis and Thrombolysis. Vol 3. New York: Raven Press; 1978:191-209.
22. Miles LA, Plow EF. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe. Biochemistry. 1986;25:6926-6933.
23. Miles LA, Dahlberg CM, Plow EF. The cell-binding domains of plasminogen and their function in plasma. J Biol Chem. 1988;263:11928-11934.
24. Xue S, Green MA, LoGrasso PV, et al. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein( a) with regulatory molecules. Thromb Haemost. 1999;81:428-435.
25. Kunkel TA, Roberts JD, Zakour RA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987;154:367-382.
26. Menhart N, Hoover GJ, McCance SG, Castellino FJ. Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation. Biochemistry. 1995;34:1482-1488.
27. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970;170:1995-1996.
28. Grella DK, Castellino FJ. Activation of human plasminogen by staphylokinase: direct evidence that preformed plasmin is necessary for activation to occur. Blood. 1997;89:1585-1589.
29. Pozzi A, Moberg PE, Miles LA, et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A. 2000;97:2202-2207.
30. van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, et al. Apoptosis in tumor necrosis factor-alpha-dependent, monocyte-mediated leukemic cell death: a function, morphologic, and flow-cytometric analysis. Exp Hematol. 1993;21:1628-1639.
31. Miles LA, Dahlberg CM, Plescia J, et al. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-Enolase as a candidate plasminogen receptor. Biochemistry. 1991;30:1682-1691.
32. Collen D, Verstraete M. Molecular biology of human plasminogen, II: metabolism in physiological and some pathophysiological conditions in man. Thromb Diath Haemorrh Suppl. 1975;34:403-408.
33. Zhang L, Gong Y, Grella DK, Castellino FJ, Miles LA. Endogenous plasmin converts Glu-plasminogen to Lys-plasminogen on the monocytoid cell surface. J Thromb Haemost. 2003;1:1264-1270.
34. Guo H, Liu D, Gelbard H, et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 2004;41:563-572.
35. Ball RY, Stowers EC, Burton JH, et al. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. 1995;114:45-54.
36. Mitchinson MJ, Hardwick SJ, Bennett MR. Cell death in atherosclerotic plaques. Curr Opin Lipidol. 1996;7:324-329.
37. Kockx MM, Knaapen WM. The role of apoptosis in vascular disease. J Path. 2000;190:267-280.
38. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
39. Moons L, Shi C, Ploplis V, et al. Reduced transplant arteriosclerosis in plasminogen-deficient mice. J Clin Invest. 1998;102:1788-1797.
40. Misasi R, Garofalo T, Di Marzio L, et al. Prosaposin: a new player in cell death prevention of U937 monocytic cells. Exp Cell Res. 2004;298:38-47.
41. Suzuki T, Kobayashi M, Isatsu K, et al. Mechanisms involved in apoptosis of human macrophages induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans in the presence of cycloheximide. Infect Immun. 2004;72:1856-1865.
42. Green H. Terminal differentiation of cultured human epidermal cells. Cell. 1977;11:405-416.
43. Ranson M, Andronicos NM, O'Mullane MJ, Baker MS. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins. Br Cancer. 1998;77:1586-1597.
44. Burtin P, Chavanel G, Andre J. The plasmin system in human colonic tumors: an immunofluorescence study. Int J Cancer. 1985;35:307-314.
45. Burgos H, Hsi BL, Yeh CJ, Faulk WP. Plasminogen binding by human amniochorion: a possible factor in premature rupture of membranes. Am J Obstet Gynecol. 1982;143:958-963.
46. Jenkins DM, O'Neill M, Mattar M, et al. Degenerative changes and detection of plasminogen in fetal membranes that rupture prematurely. Br J Obstet Gynaecol. 1983;90:841-846.
47. Altrogge LM, Monard D. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors. Anal Biochem. 2000;277:33-45.
48. Camerer E, Kataoka H, Kahn M, Lease K, Coughlin SR. Genetic evidence that protease-activated receptors mediate factor Xa signaling endothelial cells. J Biol Chem. 2002;277:16081-16087.
49. Riewald M, Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A. 2001;98:7742-7747.
50. Riewald M, Kravchenko VV, Petrovan RJ, et al. Gene induction by coagulation factor Xa is mediated by activation of PAR-1. Blood. 2001;97:3109-3116.
51. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296:1880-1882.
52. Ruf W, Dorfleutner A, Riewald M. Specificity of coagulation factor signaling. Thromb Haemost. 2003;1:1495-1503.
53. Majumdar M, Tarui T, Shi B, et al. Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha 9beta 1. J Biol Chem. 2004;279:37528-37534.
54. Pendurthi UR, Ngyuen M, Andrade-Gordon P, Petersen LC, Rao LV. Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway. Arterioscler Thromb Vasc Biol. 2002;22:1421-1426.
55. Mosnier LO, Griffin JH. Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J. 2003;373:65-70.
56. Cheng T, Liu D, Griffin JH, et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med. 2003;9:338-342.
57. Mosnier LO, Griffin JH. Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J. 2003;373:65-70.
58. Guo H, Liu D, Gelbard H, et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 2004;41:563-572.
59. Mosnier LO, Griffin JH. Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J. 2003;373:65-70.
60. Chen-Liu LW, Strickland S. Neuronal death in the hippocampus is promoted byplasmin-catalyzed degradation of laminin. Cell. 1997;91:917-925.
61. Houard X, Monnot C, Dive V, Corvol P, Pagano M. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin. J Cell Biochem. 2003;88:1188-1201.
62. Meilhac O, Ho-Tin-Noe B, Houard X, et al. Pericellular plasmin induces smooth muscle cell anoikis. FASEB J. 2003;17:1301-1303.
63. Busuttil SJ, Drumm C, Ploplis VA, Plow EF. Endoluminal arterial injury in plasminogen-deficient mice. J Surg Res. 2000;91:159-164.
64. Berberian PA, Myers W, Tytell M, Challa V, Bond MG. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol. 1990;136:71-80.
65. Bugge TH, Kombrinck KW, Xiao Q, et al. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood. 1997;90:4522-4531.
66. Bugge TH, Lund LR, Kombrinck KK, et al. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogendeficient mice. Oncogene. 1998;16:3097-3104.
67. Toku K, Tanaka J, Yano H, et al. Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro. J Neurosci Res. 1998;53:415-425.
68. Schott D, Dempfle CE, Beck P, et al. Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. N Engl J Med. 1998;339:1679-1686.
69. Lund LR, Bjorn SF, Sternlicht MD, et al. Lactational competence and involution of the mouse mammary gland require plasminogen. Development. 2000;127:4481-4492.